Method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm

Information

  • Patent Grant
  • 8663214
  • Patent Number
    8,663,214
  • Date Filed
    Wednesday, January 24, 2007
    18 years ago
  • Date Issued
    Tuesday, March 4, 2014
    11 years ago
Abstract
A system for performing an electrosurgical procedure at a surgical site is disclosed. The system includes a sensor configured to continually sense an electrical and/or a physical property of tissue at a surgical site and to generate a sensor signal as a function thereof. The system also includes a control module configured to process the sensor signal using a processor, an algorithm, and a map having one or more predetermined values. The control module is further configured to compare the sensor signal to a predetermined level to determine reliability of the sensor signal and to signal an electrosurgical generator in response to a reliable sensor signal such that the electrosurgical generator enters energy control mode, wherein the electrosurgical generator matches an output of the control signal with a predetermined value from the map.
Description
BACKGROUND

The present disclosure is directed to electrosurgery and, in particular, to a control system for an electrosurgical generator. The control system has a control algorithm that continually adjusts for changes in initial tissue conditions to enhance tissue fusion.


TECHNICAL FIELD

Electrosurgical generators are employed by surgeons in conjunction with an electrosurgical instrument to cut, coagulate, desiccate and/or seal patient tissue. High frequency electrical energy, e.g., radio frequency (RF) energy, is produced by the electrosurgical generator and applied to the tissue by an electrosurgical tool. Both monopolar and bipolar configurations are commonly used during electrosurgical procedures.


Electrosurgical techniques and instruments can be used to coagulate small diameter blood vessels or to seal large diameter vessels or tissue, e.g., veins and/or soft tissue structures, such as lung, brain and intestine. A surgeon can cauterize, coagulate/desiccate and/or simply reduce or slow bleeding, by controlling the intensity, frequency and duration of the electrosurgical energy applied between the electrodes and through the tissue. For the purposes herein, the term “cauterization” is defined as the use of heat to destroy tissue (also called “diathermy” or “electro-diathermy”). The term “coagulation” is defined as a process of desiccating tissue wherein the tissue cells are ruptured and dried.


“Vessel sealing” or “tissue fusion” is defined as the process of liquefying the collagen and elastin in the tissue so that it reforms into a fused mass with significantly-reduced demarcation between the opposing tissue structures (opposing walls of the lumen). Coagulation of small vessels is usually sufficient to permanently close them while larger vessels or tissue need to be sealed to assure permanent closure. It has been known that different waveforms of electrosurgical energy are suited for different surgical affects, e.g., cutting, coagulation, sealing, blend, etc. For example, the “cutting” mode typically entails generating an uninterrupted sinusoidal waveform in the frequency range of 100 kHz to 4 MHz with a crest factor in the range of 1.4 to 2.0. The “blend” mode typically entails generating an uninterrupted cut waveform with a duty cycle in the range of 25% to 75% and a crest factor in the range of 2.0 to 5.0. The “coagulate” mode typically entails generating an uninterrupted waveform with a duty cycle of approximately 10% or less and a crest factor in the range of 5.0 to 12.0. In order to effectively and consistently seal vessels or tissue, a pulse-like waveform is desired.


In order to optimize sealing or tissue fusion without causing unwanted charring of tissue at the surgical site or possibly causing collateral damage to adjacent tissue, e.g., thermal spread, it is necessary to control the output from the electrosurgical generator, e.g., power, waveform, voltage, current, pulse rate, etc.


It is known that measuring the electrical impedance and change thereof across the tissue at the surgical site provides a good indication of the state of desiccation or drying of the tissue during the tissue fusion or vessel sealing process. It has been observed that as the tissue dries or loses moisture, the impedance across the tissue rises. This observation has been utilized in some electrosurgical generators to regulate the electrosurgical power based on a measurement of tissue impedance. For example, commonly owned U.S. Pat. No. 6,210,403 relates to a system and method for automatically measuring the tissue impedance and altering the output of the electrosurgical generator. The alteration is based on the measured impedance across the tissue. The content of this patent is hereby incorporated by reference in its entirety.


The supply of energy may also be controlled such that it is supplied in a continuous fashion to seal vessels tissue wherein the input/output is responsive to tissue hydration/volume through feedback control. Delivery of the electrosurgical energy in pulses allows the tissue to cool between pulses. The pulses also allow some moisture to return to the tissue between pulses which is known to enhance the sealing process.


It is further known to clamp or clip excess voltage output from the electrosurgical generator by the use of avalanche devices, such as diodes, zener diodes and other devices, resulting in absorption and dissipation of excess energy in the form of heat.


Commonly owned U.S. Pat. No. 6,398,779 discloses a sensor which measures the initial tissue impedance with a calibrating pulse which, in turn, sets various electrical parameters based on a look-up table stored in a computer database. The transient pulse width associated with each pulse measured during activation is used to set the duty cycle and amplitude of the next pulse. Generation of electrosurgical power is automatically terminated based on a predetermined value of the tissue impedance across the tissue.


One significant aspect of such prior art electrosurgical generators is that often such generators use software which provides for an initial reading of one or more parameters of the tissue. However, such an initial tissue reading may be a so called “false” reading depending on the initial positioning or disposition of the electrode. The false reading may be input into the control algorithm of the electrosurgical generator which compensates for the false reading. It would be advantageous to provide a control for an electrosurgical generator which both disregards such initial, not reliable, readings where the tissue does not react and distinguishes a “false” reading from a “true” reliable reading.


Thus, a need exists to develop an electrosurgical generator which includes improved control circuitry for processing an impedance of the tissue over time and for providing continuous control of various electrical parameters (e.g., pulse frequency and intensity, voltage, current, power) of the electrosurgical generator based upon continually sensed information from the surgical site. In addition, a need exists to develop control circuitry which is designed to disregard initial readings sensed from the surgical site where no reaction with the tissue occurs.


SUMMARY

It is an object of the present disclosure to provide a system having a control module and a sensor that determines and continually monitors whether a tissue reacts to an electrode by sensing and recording a change in impedance over time.


It is an object of the present disclosure to provide for a system having a control module and a sensor that determines whether a tissue reacts to an electrode by sensing a change in the impedance per unit time and, in response to a determination that the tissue has reacted, the control module enters into an energy control mode.


It is another object of the present disclosure to provide for a system having a control module and a sensor that monitors a parameter and in response to the parameter provides a predetermined amount of current per unit time in order to prevent a rapid and uneven vaporization of liquid and fluid in the tissue with the predetermined amount of current per unit time being complementary to the monitored parameter.


It is still another object of the present disclosure to provide for a system that has a control module with a sensor that monitors a change in an impedance per unit time to determine a stability of a tissue reaction with an electrode.


It is yet another object of the present disclosure to provide for a system having a control module and a sensor that monitors a parameter and stores the parameter in a memory over time and in response to the stored parameter provides a predetermined amount of current per unit time to prevent a rapid and uneven vaporization of liquid and fluid in the tissue with the predetermined amount of current per unit time being complementary to a measurement from the stored parameter.


According to a first aspect of the present disclosure, a system for performing an electrosurgical procedure at a surgical site is disclosed. The system includes a sensor configured to continually sense an electrical and/or a physical property of tissue at a surgical site and to generate a sensor signal as a function thereof. The system also includes a control module configured to process the sensor signal using a processor, an algorithm, and a map having one or more predetermined values. The control module is further configured to compare the sensor signal to a predetermined level to determine reliability of the sensor signal and to signal an electrosurgical generator in response to a reliable sensor signal such that the electrosurgical generator enters energy control mode, wherein the electrosurgical generator matches an output of the control signal with a predetermined value from the map.


A method for performing an electrosurgical procedure at a surgical site is also contemplated by the present disclosure. The method includes the steps of continually sensing electrical and physical properties of the surgical site and generating a sensor signal as a function thereof and processing the sensor signal using a processor, an algorithm, and a map having one or more values to verify a reactance of tissue at the surgical site. The method also includes the step of entering an energy control mode, wherein the electrosurgical generator matches an output of the control signal with a value from the map, based on the determination of the reactance of tissue in the processing step.


According to another aspect of the present disclosure, a system for performing an electrosurgical procedure at a surgical site is disclosed. The system includes a sensor configured to continually sense an electrical and/or physical property of the surgical site and to generate a sensor signal as a function thereof. The system also includes a control module configured to process the sensor signal using a processor, an algorithm, and a map having one or more values. The control module is further configured to verify tissue reactance and to signal an electrosurgical generator based on the verification of tissue reactance such that the electrosurgical generator enters energy control mode. The electrosurgical generator matches an output of the control signal with a value from the map, wherein the control module is configured to recalculate the map when tissue impedance increases above a predetermined threshold and to signal the electrosurgical generator to renter energy control mode.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments will be described herein below with reference to the drawings wherein:



FIG. 1 is a schematic diagram of a control system for use with an electrosurgical generator according to the present disclosure;



FIG. 2 is a schematic diagram of a sensor module for use with the control system of FIG. 1;



FIG. 3 is a flowchart illustrating a method of operation of the control system according to one aspect of the present disclosure;



FIG. 4 is another flowchart illustrating a method of operation of the control system according to the present disclosure;



FIG. 5 is another flowchart illustrating an initial method of operation of the control system according to another aspect of the present disclosure;



FIG. 6 is a flowchart illustrating a method of operation of the control system with an energy control mode according to another aspect of the present disclosure; and



FIG. 7 is a diagram of a control system in accordance with yet another aspect of embodiment of the disclosure.





DETAILED DESCRIPTION

Reference should be made to the drawings where like reference numerals refer to similar elements throughout the various figures.


Referring to FIG. 1, there is shown a schematic diagram of one embodiment of the presently disclosed closed loop control system 10 for use with an electrosurgical generator 12. Control system 10 includes a control module 14, user interface 16 and sensor module 18. The control module 14 is operatively connected to the electrosurgical generator 12.


The control module 14 includes program instructions to detect a specified increase in a parameter at an initial time of operation to determine whether a reaction of the tissue has occurred. If no tissue reaction occurs, the control module 14 compensates and prevents initial data from entering a control algorithm. This initial data is considered to be unreliable. The parameter may be any parameter capable of being measured by the sensor module 18 of operation or calculated from data provided by the sensor module by the control module 14. In one embodiment, the parameter is a change in tissue impedance over time.


If a tissue reaction occurs and is detected, this data is considered to be reliable and the control module 14 enters an energy control mode. The energy control mode regulates electrosurgical generator 12 to output RF energy that matches a monitored tissue impedance parameter with a preset slope trajectory. The preset slope trajectory may be derived from a number of stored parameters or alternatively may be derived from a desired output or a desired effect. The preset slope trajectory is from a stored value in a map or memory and is intended to output RF energy to produce an optimal tissue seal. The stored values may be obtained by accessing a stored mapping of continuous values or alternatively a table or equivalent.


The electrosurgical generator 12 includes electrosurgical energy output stage 20 and a power supply 22. The electrosurgical output stage 20 receives power from the power supply 22 and delivers RF energy to a patient 24 via at least one electrode (not explicitly shown). As can be appreciated, one or more electrodes may be used with the electrosurgical instrument for performing monopolar or bipolar surgery.


The sensor module 18 senses various electrical and physical parameters or properties at the operating site and communicates with the control module 14. In response, the control module 14 regulates the electrosurgical output from the output stage 20. The sensor module 18 may be configured to measure or “sense” one or more various electrical or electromechanical conditions at the operating site, including but not limited to, tissue impedance, changes in tissue impedance, tissue temperature, changes in tissue temperature, leakage current, applied voltage and applied current, and other parameters.


The sensor module 18 is configured to measure one or more of these conditions continuously or in “real time”. The sensor module 18 measures the conditions such that the control module 14 can continually modulate the electrosurgical output according to a specific purpose or desired surgical intent. More particularly, analog signals provided by the sensor module 18 are converted to digital signals via an analog-to-digital converter (ADC) 26. The digital signals are then provided to the control module 14.


The control module 14, thereafter, regulates the power supply 22 and/or the electrosurgical output stage 20 according to the information obtained from the sensor module 18.


The user interface 16 is electrically connected to the control module 14 to allow the user to control various parameters of the electrosurgical energy output to the patient 24 during surgery to manually set, regulate and/or control one or more electrical parameters of the delivered RF energy. Such parameters may include but are not limited to voltage, current, power, frequency, amplified, and/or pulse parameters such as a pulse width, a duty cycle, a crest factor, and/or a repetition rate depending upon a particular purpose or to change surgical intent.


The control module 14 includes at least one microprocessor capable of executing software instructions for processing data received by the user interface 16 and the sensor module 18. The control module 14 outputs control signals to the electrosurgical output stage 20 and/or the power supply 22, accordingly. The software instructions (executable by the control module) are stored in an internal memory in the control module 14, an internal or external memory bank accessible by the control module and/or an external memory, e.g., an external hard drive, floppy diskette, CD-ROM, etc. or any other recordable medium. Control signals from the control module 14 to the electrosurgical generator 12 may be converted to analog signals by a digital-to-analog converter 28.


The power supply 22 is a high voltage DC power supply for producing electrosurgical current, e.g., radiofrequency (RF) current. Signals received from the control module 14 control the magnitude of the voltage and current output by the DC power supply. The electrosurgical output stage 20 receives the output current from the DC power supply and generates one or more pulses or a continuous sinusoidal waveform via a waveform generator (not explicitly shown).


The pulse parameters, such as pulse width, duty cycle, crest factor and repetition rate are regulated in response to the signals received from the control module 14. Alternatively, the power supply 22 may be an AC power supply, and the electrosurgical output stage 20 may vary the waveform of the signal received from power supply 22 to achieve a desired waveform.


The user interface 16 may be local to, adjacent to, or remote from the control module 14. A user may enter data such as the type of electrosurgical instrument being used, the type of electrosurgical procedure to be performed, and/or the tissue type upon which the electrosurgical procedure is being performed. The generator 12 may also be configured to recognize one or more parameters automatically, e.g., based on the type of the electrosurgical instrument being used.


The closed loop control system 10, in particular the sensor module 18, may include one or more smart sensors. The sensors provide feedback to the surgeon relating to one or more of these physical parameters. Furthermore, the user may enter commands, such as a target effective voltage, current or power level to be maintained, or a target response, e.g., change in regulation of the power supply 22 and/or electrosurgical output stage 20, to changes in sensed values, such as an effective change in voltage, current and/or power level as a function of the changes. The user may also enter commands for controlling electrical parameters of the RF energy, delivered by the electrosurgical generator 12, as described above. A default value is provided for the above target levels and target responses.


The sensor module 18 includes a number of sensors (not explicitly shown) strategically located for sensing various properties or conditions at or proximate points “A” and “B” as shown in FIG. 1. Sensors positioned at or proximate point “A” (hereinafter referred to as at point “A”) sense one or more properties and/or parameters of electrosurgical output from electrosurgical output stage 20, and/or properties, parameters or conditions prior to surgical effect of the currently administered electrosurgical energy during the surgical procedure. Sensors positioned at point “A” may be provided with or attached proximate the generator 12.


Sensors (not explicitly shown) positioned at or proximate point “B” (hereinafter referred to as at point “B”) sense one or more parameters, properties and/or conditions at or across the operating site prior to the surgical procedure and/or in response to surgical effect during the surgical procedure and these sensors may be included with the electrosurgical instrument (e.g., on one end or opposing end effectors) or attached proximate the operating site. In one embodiment, optical sensors, proximity sensors, temperature sensors may be used to detect certain tissue characteristics, and electrical sensors may be employed to sense other parameters of the tissue or operating effects. Point “A” may be proximate the surgical site “B” at a location where the signals outputted by the generator 12 are propagated before they are applied or approximately when they are applied to the surgical site “B”.


The sensors are provided with leads or possibly a suitable wireless device for transmitting information to the control module 14. The information may be provided directly to the control module and/or provided to the control module via the sensor module 18 and/or the analog to digital converter 26. The sensor module 18 may also have a device for receiving information from multiple sensors. The sensor module 18 may provide the information and the source of the information (e.g., the particular sensor providing the information) to the control module 14.


Referring now to FIG. 2, there is shown a block diagram of the sensor module 18. The sensor module 18 has a real-time voltage sensing system 30 and a real-time current sensing system 32 for sensing real-time values for applied voltage and current at the surgical site “B”. The sensor module 18 also has a real-time voltage sensing system 34 and a real-time current sensing system 36 for sensing real-time values of signals returned from the patient at a point “A”.


The sensor module 18 further has an RMS voltage sensing system 38 and an RMS current sensing system 40 are also included for sensing and deriving RMS values for applied voltage and current at the surgical site “B”. An RMS voltage sensing system 42 and an RMS current sensing system 44 are included for sensing and deriving RMS values of signals at point “A”. The sensor module 18 also has a temperature sensing system 46. The temperature sensing system 46 is included for sensing tissue temperature at the surgical site “B”.


Real-time and RMS current and voltage sensing systems are known in the art. The sensor module 110 may further include other sensors (not explicitly shown) for sensing voltage and current output by the generator.


The measured or sensed values are further processed, either by circuitry and/or a processor (not explicitly shown) in the sensor module 18 and/or by the control module 14, for deriving changes in sensed values and tissue impedance at the surgical site “B”.


Tissue impedance and changes in tissue impedance may be determined in one embodiment by measuring the voltage and/or current across the tissue and/or calculating changes thereof over time, and comparing the voltage and current values to known and/or desired values associated with various tissue types for use by the control system 10 to drive electrical output to achieve desired impedance and/or change in impedance values.


As can be appreciated, these known and/or desired values, tissue types and ranges may be stored in an internal look-up table, “a continuous value map” or in an external searchable memory. Commonly owned U.S. Pat. No. 6,398,779, U.S. Pat. No. 6,203,541, U.S. Pat. No. 5,827,271 and U.S. patent application Ser. No. 10,073,761 disclose methods for measuring tissue impedance, and are all incorporated by reference herein in their entirety.


By deriving tissue impedance (or other physical and electrical parameters) from real-time value(s) provides the benefit of monitoring real-time tissue impedance and/or changes in tissue impedance. As the surgical procedure proceeds, it is believed that the tissue impedance fluctuates in response to removal and restoration of liquids from the tissue at the surgical site “B”. As the control module 14 monitors the tissue impedance and changes in tissue impedance (or other physical and electrical parameters) the control module regulates the power supply 22 and electrosurgical output stage 20 accordingly for achieving the desired and optimal electrosurgical effect. Such a system is described in United States Published Patent Application Number US 2004/0015163 A1 to Buysse, et al. which is herein incorporated by reference in its entirety.


Before beginning an electrosurgical procedure, an operator of the electrosurgical instrument enters information via the user interface 16. Information entered includes, for example, the type of electrosurgical instrument being used, the type of procedure being performed (i.e., desired surgical effect), the type of tissue, relevant patient information, and a control mode setting. The control mode setting determines the amount of or type of control that the control module 14 will provide. The one or more sensors (not explicitly shown) may also be included to automatically provide information to the control module 14 relating to tissue type, initial tissue thickness, initial tissue impedance, etc.


The modes include, but are not limited to, one or a combination of one or more of the following modes: a first mode, a second mode, a third mode or any number of modes. The first mode is defined as the stage when the control module 14 maintains a steady selected output power, current and/or voltage value at site “A”.


The second mode is defined as the stage when the control module 14 maintains a steady selected output power, current and/or voltage value at site “B”. The third mode is defined as the stage when the control module 14 maintains a variable selected output power, current and/or voltage values at site “A” which is dependent upon (i.e., a function of) time value(s) and/or sensed parameter(s) or changes in sensed parameter(s) during the procedure. The fourth mode is defined as the stage when the control module 14 maintains a variable selected output power, current and/or voltage values at site “B”, which is dependent upon (i.e., a function of) time value(s) and/or sensed parameter(s) or changes in sensed parameter(s) during the procedure.


Functions performed on the time value(s) and sensed properties(s) include operations such as calculations and/or look-up operations using a table or map stored by or accessible by the control module 14. The control module 14 processes the selected output power, current and voltage values, such as by performing calculations or table look up operations from a database, to determine power control signal values and output control values.


The control module 14 determines an initial setting for control signals to the power supply 22 and the output stage 20 by using and/or processing operator-entered data or settings, performing calculations and/or accessing a look-up table stored by or accessible by the control module 14.


Once the electrosurgical procedure begins, the sensors 30 through 46 of sensor module 18 sense various physical and electrical properties and provide feedback to the control module 14 through the converter 26. The control module 14 processes the feedback information in accordance with the pre selected mode, as well as any additional operator-entered commands entered during the procedure. The control module 14 then sends control information to the power supply 22 and the output stage 20. The electrosurgical generator 12 may be provided with override controls, to allow the operator to override the control signals provided by the control module 14, if needed, e.g., by entering override commands via the user interface 16 or at any other suitable location.


The electrical impedance and change thereof across the tissue at the surgical site indicated on FIG. 1 as reference letter “B” provides a favorable indication of the state of desiccation or drying of the tissue. As the tissue dries or looses moisture, the impedance across the tissue rises. This observation has been used in some electrosurgical generators to regulate the electrosurgical power based on a measurement of tissue impedance. For example, commonly owned U.S. Pat. No. 6,210,403 which is herein incorporated by reference relates to a system and method for automatically measuring the tissue impedance and altering the output of the electrosurgical generator based on the measured impedance across the tissue.


As the impedance of the tissue changes the current changes inversely proportionally if the voltage remains constant. This is basically defined by Ohm's law wherein, V=IR wherein V is the voltage, I is the current, and I is the current along the electrode in milliamps. When the tissue impedance increases, the current will decrease. If the tissue impedance decreases, the current will increase. Increases/decreases in the current may be detector by the sensor module 18.


Referring now to FIG. 3, there is shown a general basic block diagram of a software algorithm that is executed by the control module 14. The control module 14 controls one of or both of the power supply 22 and/or the electrosurgical output stage 20 and at step 48, the control module 14 controls the power supply and/or the electrosurgical output stage to emit a low power initial pulse of RF energy. The pulse is used to sense at least one electrical characteristic of the tissue.


Next, the sensor module 18 communicates the data to the converter 26 and the converter communicates a digital signal to the control module 14. The control module 14 measures tissue impedance or another electrical characteristic shown as step 50. Thereafter, the control module 14 uses the sensed electrical characteristic of the tissue as an input into the determination of the initial radio frequency parameters shown as step 52. At step 54, the control module 14 may vary the output power parameters based in part on the current transient or in this instance using the impedance, as described in commonly-owned U.S. Pat. No. 6,398,779, the contents of which are hereby incorporated by reference in its entirety.


Referring now also to the logic flow diagram of FIG. 4, the impedance sensing feature is implemented at the beginning of a cycle, for example, a vessel seal cycle or another surgical cycle. One skilled in the art should appreciate that the cycle may be any electrosurgical surgical operation known in the art. The electrosurgical generator 10 senses at least one electrical characteristic of the tissue, for example, impedance, I-V phase rotation, or the output current, by using a short burst of RF energy shown as step 55. The electrical characteristic of the tissue such as the tissue impedance may be measured at any frequency or power level, but is performed at the same frequency as the intended working frequency (e.g., 470 kHz). A short burst of RF energy from the electrosurgical output stage 20 (less than about 200 milliseconds, and about 100 milliseconds) is a 470 kHz sine wave with approximately 5 W of power. However, one skilled in the art should appreciate that other configurations are also possible.


The initial pulse RF power is made low at step 55, and the pulse time is made as short as possible, to enable an initial tissue electrical characteristic measurement to be made such as the tissue impedance without excessively heating the tissue at step 56. Next, the control module 14 using the tissue impedance or another electrical characteristic determines the initial set of output power parameters shown as step 58. Some of the values that are obtained include power, maximum voltage, starting voltage, minimum voltage, voltage decay, voltage ramp, maximum RF on time, maximum cool scale factor, pulse minimum, pulse dwell time, pulse off time, and the pulse desired width.


The control module 14 then modifies the initial set of parameters per seal intensity control input shown as step 60 and applies a subsequent RF energy pulse shown as step 62 and a measure of the current transient pulse width is made at step 64.


A determination is made at step 66 by the control module 14. The determination is whether there is a current transient is present or whether there is a short lived oscillation between the first pulse and a successive pulse caused by one or more parameters such as the tissue impedance, change in voltage or current load. If there is a current transient present, the control is passed to step 68 as indicated by the broken line in FIG. 4. If there is not a current transient present, the control is passed to step 78 as shown by the broken line in FIG. 4.


At step 68, a determination is made as to whether the pulse of the current transient is sufficiently wide. If the pulse is sufficiently wide or in the range of 500 to 1000 ms, then the control module 14 assumes a presence of a large amount of tissue, or that the selected tissue requires more RF energy to desiccate. If sufficiently wide, the control passes to step 70. If not sufficiently wide, the control passes to step 72.


At step 70, the dwell time is increased and a reduction of amplitude is made of the next RF pulse. If the pulse of the current transient is not sufficiently wide or is narrow, for example about 250 ms or less, then the control module 14 can assume a small amount of tissue, or a tissue type that requires little RF energy is present. The dwell time may be shortened and a reduction in the amplitude of the delay time of the next RF pulse can be made at step 72.


A decision is made at step 74 as to whether the amplitude of the signal is less than the ending amplitude. If the determination at step 74 is affirmative then the control module 14 stops the signal being emitted from the electrosurgical output stage 20 at step 76. The signal is terminated because the operation is complete and the tissue has been sealed.


If the decision at step 74 is at the negative, control passes to step 62 and the subsequent RF energy pulse is applied. If the electrical transient is not present at the determination block 66 then control passes to step 78. At step 78, given a negative output from the determination block at step 66, the tissue has either not yet begun to desiccate, a short in the system has occurred, or the seal cycle is complete. At step 78, if the impedance is less than a low impedance value, the control module 14 will assume that a shorted electrode or instrument has occurred at step 80 and terminate operation thereof.


At step 78 if the low impedance threshold has not occurred, then control passes to decision block 82. At decision block 82, if the measured impedance is greater than a predetermined high impedance threshold value, then the control passes to step 84. At step 84, control module 14 assumes that the tissue seal has been achieved and will terminate operation.


At decision block 82, if the measured impedance is not greater than a predetermined high impedance threshold value, the control passes to step 86.


At step 86, if the tissue impedance is found to be between the low impedance and the high impedance values, then control passes to a determination of whether a maximum amount of RF time has been exceeded. If this decision at step 86 is in the affirmative, the control module 14 assumes that the seal has not been made for a reason. Control will pass to step 88 and the operation is terminated for reason that the tissue seal has been assumed to be unsuccessful. Alternatively, if the maximum amount of time is not exceeded then the controller assumes that the tissue has not yet received enough RF energy to start desiccation. If the maximum amount of time is not exceeded, control passes to step 62 as indicated by a dotted line for further operation.


The initial conditions of the tissue seal or the initial conditions of touching the applicator with the electrode and applying the RF energy to the tissue are significant. Generally existing generators at step 58 of FIG. 4 will operate as follows: if the starting range was in a lower or low range, the initial power is made lower. Also, generally, if the sensed impedance was high or in a higher range, the initial power and starting voltage is made higher. The initial parameters may be obtained by the control module 14 shown in FIG. 1 by viewing a parameter lookup table. However, for an optimal tissue seal to occur, it is desirable to modulate and control the vaporization rate of fluids in the tissue. If the fluid in the tissue is heated in an uneven manner or in a manner that is too rapid, the fluid or liquid in the tissue will rapidly heat per unit time by the RF energy to expand and quickly traverse out of the tissue.


This “pop” or fluid rapidly escaping the tissue per unit time is disfavored for an optimal tissue seal condition. Thus, it is desirable to identify the initial point of fluid vaporization by the RF energy to modulate and decrease the amount of RF energy from either the electrosurgical output stage 20 or the power supply 22 to prevent such a rapid fluid vaporization for an ideal tissue seal and for a more productive initial operation of the electrosurgical generator 12, particularly at step 55 through 58 of FIG. 4.


Referring now to FIG. 5, the control module 14 further has a software algorithm to control either the power supply 22 and/or the electrosurgical output stage 20 in response to an initial tissue impedance reading or reaction. The software algorithm of FIG. 5 determines, by sensing one or more parameters, whether a tissue reactance occurs. When the electrode or applicator is placed on the tissue at the surgical site “B” (shown on FIG. 1), and RF energy is pulsed from the applicator, an initial reading is taken and a property or parameter such as tissue impedance is sensed by the sensor module 18 at step 90. One skilled in the art should appreciate that various parameters can be sensed by the sensor module 18 such as a control variable, an energy, a temperature, a current, or other previously mentioned parameters that are all within the scope of the present disclosure.


Control is passed to a decision block 92. At the decision block 92, a determination is made. The determination is as to whether the initial reading has a parameter such as an impedance that rises or falls above some predetermined threshold. If the initial reading has an impedance value that is above, or below a predetermined threshold then the reading is disregarded. The “false” tissue impedance reading thus is not allowed to cycle through the algorithm of the control module 14. Instead, the control is passed to step 94 to disregard the initial reading and then return to step 90 to continue sensing the impedance at surgical site “B” to allow for tissue impedance readings to cycle through the algorithm of the control module but only after a tissue reactance is determined.


Referring again to FIG. 5, there is shown the logic flow diagram of an initial cycle. The initial impedance reading of step 90 is output to decision block 92. At decision block 92, if the sensed impedance value is a predetermined amount above the maximum impedance value that is a preset maximum impedance value threshold, a decision is made at step 92. If the decision is in the affirmative, then the tissue impedance reading is disregarded at step 94. Thereafter, the cycle is continued with the RF energy being regulated at the electrosurgical stage output 20 and being output at a low power initial pulse of RF energy level.


If the decision is in the negative at step 92, control is passed to decision block 96. At decision block 96, if the sensed impedance value is an amount that is below the minimal impedance value or a preset minimal impedance value threshold, a decision is made at step 96.


If the decision is in the affirmative, then the control module 14 assumes that a tissue reactance has not occurred and the reading is disregarded at step 94, and operation is continued with the energy regulated at the electrosurgical stage output 20 and being output at an energy level that is a low power initial pulse of RF energy for sensing the properties at the surgical site “B” at step 90.


If the level is between the preset maximum impedance value threshold and the preset minimum impedance value threshold then operation continued to step 98 and the sensor module 18 senses parameters including impedance and the control module 14 continually processes sensed properties at step 98. The control then passes to step 100 to continually generate a power supply control signal and RF output in accordance, for example, with a predetermined curve based on power, impedance, current voltage, etc.


Referring now to another logic flow diagram as FIG. 6, the algorithm also has an energy control mode that supplies energy to the applicator or electrode to prevent vaporizing the fluids in the tissue. Referring now to FIG. 6, step 102 indicates to apply a low power initial pulse of RF energy to the tissue. Parameters are detected by the sensor module 18, and the control module 14 determines the tissue impedance or another parameter from the sensed parameters in step 104. Here, a reliable parameter may be stored in memory. Thereafter, control will pass to decision block 106.


At decision block 106, a decision is made as to whether the tissue reacts in response to the RF energy received. If so, the algorithm provides for an energy control mode to avoid any “pop” effect by the electrode applying RF energy to the tissue. The reaction is defined by a specified increase in impedance above a minimum value reached previously. The specified increase in impedance is loaded by the control module 14 based on tissue type and/or properties as well as electrosurgical instruments being utilized. The minimum value reached previously is obtained by the control module 14 by accessing a stored map of continuous values, or alternatively, of a table or equivalent. If the tissue does react by indicating that the impedance is a specified increase above the minimum value reached previously, the electrosurgical generator 12 passes control to step 108 and the generator enters an energy control mode. If the tissue does not react at step 106, the control passes to step 110.


At step 110, another decision is made as to whether the tissue reacts in response to the RF energy received. Here, the tissue reaction is defined by a specified drop or decrease in impedance below a set value for a period of time does not occur. The control module 14 assumes that if by this specified drop or decrease in impedance below a set value for a period of time at step 110 occurs then the reaction event is not stable. The control module 14 then assumes that the tissue has not reacted. The minimum value reached may be any substantially low impedance value or range of values that are complementary to indicate that no tissue reaction occurs such as 10 to 20 Ohms. If the tissue does react by indicating that the impedance is above the minimum set value to indicate that the tissue reacts, the electrosurgical generator 12 passes control to step 108 and the generator enters the energy control mode. If the tissue does not react at step 110, the control will pass to step 102. Optionally, the control module 14 may further have a timer. The timer may provide the control module 14 with a function that once a preset amount of time elapses without any tissue reactance during the time interval, control passes to step 102.


The energy control mode is utilized to reduce vaporization of the liquid or fluid in the tissue. RF energy supplied by the electrosurgical output stage 20 will be controlled in a predetermined fashion to reduce vaporization. The output of the electrosurgical output stage 20 at the energy control mode may match or be complementary to an actual tissue impedance that is monitored by the sensor module 18 or may match to a preset amount or a preset slope of a change of an observed impedance per unit time. The preset amount in the energy control mode at step 108 is impedance that has a preset slope trajectory with time. The preset amount per unit time may be stored in a memory or a recorded medium or may be input or loaded into the system 10 using the user interface 16.


The preset amount has a preset slope trajectory that is accessed from a database or is input using the user interface 16 or is the integral of impedance over time (dz/dt) at step 112. The control module 14 thus adjusts the output of the electrosurgical output 20 and/or the power from the power supply 22 to match the preset slope trajectory at step 112 to modulate the RF energy output from the electrosurgical output 20 at the outset or initial conditions of operation. Control will then pass back to step 104 to determine the tissue impedance at step 104 at a subsequent time.


Referring now to FIG. 7, there is shown a block diagram of another embodiment of the control module 14 having two control loops or an inner loop and an outer loop. The terms “inner” and “outer” form no spatial limitations to the control module 14 and are simply to distinguish between modules of the control module. The inner loop is controlled by an inner loop control module 114 and the outer loop is controlled by a second outer loop control module 116. Both are software modules that are controlled by a processor or other suitable analog circuit of the control module 14. Both the inner control module and the outer control module receive signals from the sensor module 18 as is known in the art. The inner loop control module 114 controls one or more parameters and controls a variable of the generator.


The inner loop control module 114 continually receives real time signals or sensed values from the sensor module 18. The inner loop control module 114 also has a map of continuous values 118. The inner loop control module 114 consults with the map 118. The inner loop control module 114 obtains a desired inner loop value for the impedance or other parameter currently being sensed and derived by the signal being output by the sensor module 18. The inner loop control module 114 uses an algorithm to compare real time sensed values to the desired inner loop values and then outputs a control signal to the electrosurgical output stage 20. The control signal may control one or more parameters of the electrosurgical generator 10 such as for example current, power, voltage, duty cycle, frequency, waveform shape and other parameters.


The outer loop control module 116 is layered over the inner loop control module 114 and provides for an additional control of a variable for reaching a desired output value or effect. The outer loop control module 116 continually receives sensed values, such as current, voltage and temperature from the sensor module 18 at a time (t seconds), (t+1 seconds), (t+2 seconds), (t+3 seconds) for a predetermined amount of time etc. The outer loop control module 116 then performs calculations of the sensed values and stores the values.


The stored values include a value for a change in impedance (dz/dt) that is obtained in accordance with: dz/dt=(z×z(old))/(t×t(old)), wherein Z is impedance measure at time t, and wherein Z(old) is a previous impedance reading being measured at time t(old).


The outer loop desired value for a control value is obtained by accessing a stored map of continuous values shown as reference numeral 120. The map 120 stores a desired rage of parameters including a change in impedance per unit time. The desired rate of a change in impedance per unit time or dz/dt is stored in the map 120, may be constant, or may depend on a stage of the tissue seal cycle or may change over time. One skilled in the art should appreciate that the tissue is in a dynamic state during a surgical procedure and the outer control module 116 monitors a rate of change throughout the procedure, and stores such a change in map 120.


The outer loop control module 116 compares a real time sensed value of a rate of change in the impedance at time (t) to the respective desired value at time (t) obtained from the map 120. The outer loop control module 116 then determines if a desired outer value is met. If not met the control module 116 determines the ratio of a difference between the real time value and the desired outer value to the desired outer value.


If the desired outer value is not met, the outer loop control module 116 then generates a set point value. The set point value is provided to the inner loop control module 114. The set point value may be raised when the real time value for the rate of change of impedance is lower than desired. The set point value may be a ratio signal. The ratio signal is applied to the control signal or for altering the inner map 118 by raising or lowering a plotted curve of the inner map along a Y axis to form an altered inner map value.


The ratio signal is a proportional integral derivative control signal as is known in the art as (PID). The inner loop control module 114 reacts instantaneously and accesses the altered inner map values or series of inner mapped values. The inner loop control module 114 obtains a desired inner value from the outer loop and makes a comparison. The comparison is between the real time value of the control variable and the desired value. The inner control module then generates an RF command for the control variable without exceeding the desired inner value, and outputs the RF command to the electrosurgical output stage 20 for controlling voltage, current and/or power needed for achieving a desired tissue effect. The outer loop control module 116 uses the real time value of rate of change of impedance, temperature, rate of change of temperature, and/or total energy delivered to determine if a desired outer value has been reached which indicates completion of a tissue seal. Upon determination of seal completion, a stop signal is generated for stopping the sealing process. The outer loop continues to monitor, receive and process sensed values from the senor module 18.


A control of current, voltage and/or power by the inner loop control module 116 improves system stability and control capabilities in low impedance ranges which are critical for seal initiation. Such low impedance ranges are about 0 to 20 ohms. The outer loop control module 116 enhances the control module's ability to control sealing in accordance with desired trends or events, to change seal intensity by changing the rate of change of impedance, and to enhance uniform sealing of tissue, i.e., normalize tissue in terms of variability, including tissue hydration, volume and composition.


With feedback control and continuous sensing of the tissue's condition, there is not a need to switch control variables (i.e., low/high end break points), which improves system stability as explained above.


Referring now again to the energy control mode as shown as step 108 in FIG. 6, the outer loop control module 116 matches the impedance monitored to a preset slope trajectory by accessing a stored preset slope trajectory using values stored in map 120 as indicated by step 112 in FIG. 6. Thereafter, the outer loop control module 116 outputs the matched preset slope trajectory by generating a ratio signal to the inner loop control module 114. The ratio signal controls the RF signal using the matched preset slope trajectory. The outer loop control module 116 then continues to determine the tissue impedance. A significant advantage of the present disclosure is that the control module 14 in this manner may continually adjust to changes in tissue conditions without any “pop” or vaporization of the fluid in the tissue. The control system 10 can apply RF energy that is effectively controlled by one or more characteristics of the tissue rather than one or more program instructions that are independent of the characteristics of the tissue.


When in energy control mode, the control system 10 will continuously monitor for a drop in impedance below a predetermined value over time, signifying the reaction was not stable. The delivered output power will continue to be adjusted in accordance with the slope trajectory. When the tissue impedance, however increases above a predetermined level, the impedance slope trajectory stored in map 120 is recalculated. Once the tissue impedance is sensed to increase above the predetermined level, the “y” axis of the map 120 is recalibrated. The zero-point of the graph in map 120 is aligned with the time point “t” (threshold point), i.e., the point in time where the impedance signal calculated by the inner loop control module 114 increases above the predetermined or threshold point. After a stable reaction point is identified, the associated time that the impedance or signal passed through the threshold is recorded by the outer control module 116 in the map 120. This threshold time marks the initial slope trajectory point as the “t” (threshold point) in the map 120. The outer control module 116 then uses the initial slope trajectory point stored in the map 120 to control the inner control module 114 and applies the ratio signal from that point onwards so that data previously recorded from the initial slope trajectory point can be disregarded.


Thereafter, this correction or reset can lead to a RF pulsing that is effectively controlled by the tissue rather than a preset software to avoid any vaporization of fluids in the tissue at the initial setting. It is envisioned that the present disclosure algorithm, system and method described herein can be used with both the monopolar and bipolar vessel sealing system or tissue fusion devices such as those described in commonly owned U.S. patent application Ser. Nos. 10/460,926, 10/873,860 and U.S. Provisional Ser. No. 60/722,177. The entire contents of all of which are herein incorporated by reference in their entirety.


It should be understood that the foregoing description is only illustrative of the present disclosure. Various alternatives and modifications can be devised by those skilled in the art without departing from the disclosure. Accordingly, the present disclosure is intended to embrace all such alternatives, modifications and variances. The embodiments described with reference to the attached drawing figures are presented only to demonstrate certain examples of the disclosure. Other elements, steps, methods and techniques that are insubstantially different from those described above and/or in the appended claims are also intended to be within the scope of the disclosure.

Claims
  • 1. A system for performing an electrosurgical procedure at a surgical site, the system comprising: a sensor configured to continually sense at least one of an electrical and physical property of tissue at a surgical site and to generate a sensor signal as a function thereof; anda control module configured to process the sensor signal using a processor, a control algorithm, and a map having at least one predetermined value, the control module further configured to compare the sensor signal to a predetermined level to determine reliability of the sensor signal and to provide a control signal to an electrosurgical generator in response to a reliable sensor signal such that the electrosurgical generator enters energy control mode, during which the electrosurgical generator matches an output of the control signal with a predetermined value from the map and the control module determines whether a tissue reactance is stable by monitoring whether tissue impedance dwells below a predetermined threshold for a predetermined period of time;wherein the control module (i) distinguishes between reliable and unreliable parameter data and (ii) is prevented from inputting unreliable initial parameter data to the control algorithm, the unreliable initial parameter data defined as parameters having values above predetermined maximum values or below predetermined minimum values.
  • 2. A system according to claim 1, wherein the control module compares the sensor signal to a predetermined level and determines the reliability of the sensor signal at an initial operation of the system.
  • 3. A system according to claim 1, wherein at least one parameter of the map is recalculated based in part on a control signal derived from a reliable sensor signal.
  • 4. A system according to claim 1, wherein during the energy control mode the electrosurgical generator is configured to adjust a parameter selected from the group consisting of a voltage adjustment, a current adjustment, a pulse width adjustment, a pulse frequency adjustment, an amplitude adjustment, a crest factor adjustment, a duty cycle adjustment, a repetition rate adjustment, a waveform shape adjustment, and a wave adjustment.
  • 5. A system according to claim 1, further comprising a user interface which is configured to allow a user to select a surgical parameter selected from the group consisting of a type of instrument being connected to the generator, a tissue type, and a desired surgical effect.
  • 6. A system according to claim 1, wherein the control module determines an impedance from the sensor signal, and wherein the control module is configured to compare the impedance to a predetermined level to verify the tissue reactance, wherein once reactance is verified the control signal is configured to reference a stored value corresponding to the impedance from the map, and wherein the control module is configured to control the generator based in part on the stored value.
  • 7. A system according to claim 6, wherein the stored value is a preset slope trajectory of a change of the impedance per unit of time.
  • 8. A system according to claim 6, wherein the stored value is derived from past stored data recorded in a memory.
  • 9. A system according to claim 6, wherein the stored value is a change in impedance over time from the map.
  • 10. A system according to claim 6, wherein if the impedance drops below a predetermined threshold over a predetermined period of time, the control module disregards the measured impedance, and the control module thereafter continues to sense whether the tissue reactance occurs.
  • 11. A system according to claim 6, wherein the control module disregards the impedance when no tissue reactance is determined.
  • 12. A system according to claim 1, wherein the sensor is selected from the group consisting of a voltage sensor, a current sensor, a temperature sensor, an RMS voltage sensor, an RMS current sensor, and a leakage current sensor.
  • 13. A method for performing an electrosurgical procedure at a surgical site on a patient, the method comprising: continually sensing electrical and physical properties of the surgical site and generating a sensor signal as a function thereof;processing the sensor signal using a processor, a control algorithm, and a map having at least one value to verify a reactance of tissue at the surgical site; andentering an energy control mode, during which the electrosurgical generator matches an output of the control signal with a value from the map, based on the determination of the reactance of tissue in the processing step and the control module determines whether a tissue reactance is stable by monitoring whether tissue impedance dwells below a predetermined threshold for a predetermined period of time;wherein the control module (i) distinguishes between reliable and unreliable parameter data and (ii) is prevented from inputting unreliable initial parameter data to the control algorithm, the unreliable initial parameter data defined as parameters having values above predetermined maximum values or below predetermined minimum values.
  • 14. The method according claim 13, wherein the sensed electrical and physical properties of the surgical site of the continually sensing step are disregarded if no tissue reactance is verified at the surgical site.
  • 15. The method according claim 13, wherein the processing step further includes comparing the sensor signal to a predetermined level and determining a reliability of the sensor signal.
  • 16. A system comprising: a sensor configured to continually sense at least one of an electrical and physical property of the surgical site and to generate a sensor signal as a function thereof; anda control module configured to process the sensor signal using a processor, a control algorithm, and a map having at least one value, the control module further configured to verify a tissue reactance and to provide a control signal to an electrosurgical generator based on the verification of tissue reactance such that the electrosurgical generator enters energy control mode, the electrosurgical generator matches an output of the control signal with a value from the map, during which the control module is configured to recalculate the map when tissue impedance increases above a predetermined threshold and to signal the electrosurgical generator to reenter energy control mode and the control module determines whether the tissue reactance is stable by monitoring whether tissue impedance dwells below a predetermined threshold for a predetermined period of time;wherein the control module (i) distinguishes between reliable and unreliable parameter data and (ii) is prevented from inputting unreliable initial parameter data to the control algorithm, the unreliable initial parameter data defined as parameters having values above predetermined maximum values or below predetermined minimum values.
  • 17. A system according to claim 16, wherein during the energy control mode the electrosurgical generator is configured to adjust a parameter selected from the group consisting of a voltage adjustment, a current adjustment, a pulse width adjustment, a pulse frequency adjustment, an amplitude adjustment, a crest factor adjustment, a duty cycle adjustment, a repetition rate adjustment, a waveform shape adjustment, and a wave adjustment.
  • 18. A system according to claim 16, further comprising a user interface which is configured to allow a user to select a surgical parameter selected form the group consisting of a type of instrument being connected to the generator, a tissue type, and a desired surgical effect.
  • 19. A system according to claim 16, wherein the control module determines an impedance from the sensor signal, and wherein the control module is configured to compare the impedance to a predetermined level to verify a tissue reactance, wherein once reactance is verified the control signal is configured to reference a stored value corresponding to the impedance from the map, and wherein the control module is configured to control the generator based in part on the value.
  • 20. A system according to claim 19, wherein if the impedance drops below a predetermined threshold over a predetermined period of time, the control module disregards the measured impedance, and the control module thereafter continues to sense whether tissue reactance occurs.
PRIORITY CLAIM

This application claims priority to a U.S. Provisional Application Ser. No. 60/761,498 entitled “A Method and System For Controlling An Output of a Radio-Frequency Medical Generator Having an Impedance Based Control Algorithm” filed by Craig Weinberg et al. on Jan. 24, 2006. The entire contents of which is incorporated by reference in its entirety herein.

US Referenced Citations (834)
Number Name Date Kind
1787709 Wappler Jan 1931 A
1813902 Bovie Jul 1931 A
1841968 Lowry Jan 1932 A
1863118 Liebel Jun 1932 A
1945867 Rawls Feb 1934 A
2827056 Degelman Mar 1958 A
2849611 Adams Aug 1958 A
3058470 Seeliger et al. Oct 1962 A
3089496 Degelman May 1963 A
3154365 Crimmins Oct 1964 A
3163165 Islikawa Dec 1964 A
3252052 Nash May 1966 A
3391351 Trent Jul 1968 A
3413480 Biard et al. Nov 1968 A
3436563 Regitz Apr 1969 A
3439253 Piteo Apr 1969 A
3439680 Thomas, Jr. Apr 1969 A
3461874 Martinez Aug 1969 A
3471770 Haire Oct 1969 A
3478744 Leiter Nov 1969 A
3486115 Anderson Dec 1969 A
3495584 Schwalm Feb 1970 A
3513353 Lansch May 1970 A
3514689 Giannamore May 1970 A
3515943 Warrington Jun 1970 A
3551786 Van Gulik Dec 1970 A
3562623 Farnsworth Feb 1971 A
3571644 Jakoubovitch Mar 1971 A
3589363 Banko Jun 1971 A
3595221 Blackett Jul 1971 A
3601126 Estes Aug 1971 A
3611053 Rowell Oct 1971 A
3641422 Farnsworth et al. Feb 1972 A
3642008 Bolduc Feb 1972 A
3662151 Haffey May 1972 A
3675655 Sittner Jul 1972 A
3683923 Anderson Aug 1972 A
3693613 Kelman Sep 1972 A
3697808 Lee Oct 1972 A
3699967 Anderson Oct 1972 A
3720896 Bierlein Mar 1973 A
3743918 Maitre Jul 1973 A
3766434 Sherman Oct 1973 A
3768482 Shaw Oct 1973 A
3801766 Morrison, Jr. Apr 1974 A
3801800 Newton Apr 1974 A
3812858 Oringer May 1974 A
3815015 Swin et al. Jun 1974 A
3826263 Cage et al. Jul 1974 A
3848600 Patrick, Jr. et al. Nov 1974 A
3870047 Gonser Mar 1975 A
3875945 Friedman Apr 1975 A
3885569 Judson May 1975 A
3897787 Ikuno et al. Aug 1975 A
3897788 Newton Aug 1975 A
3898554 Knudsen Aug 1975 A
3905373 Gonser Sep 1975 A
3913583 Bross Oct 1975 A
3923063 Andrews et al. Dec 1975 A
3933157 Bjurwill et al. Jan 1976 A
3946738 Newton et al. Mar 1976 A
3952748 Kaliher et al. Apr 1976 A
3963030 Newton Jun 1976 A
3964487 Judson Jun 1976 A
3971365 Smith Jul 1976 A
3978393 Wisner et al. Aug 1976 A
3980085 Ikuno Sep 1976 A
4005714 Hilebrandt Feb 1977 A
4024467 Andrews et al. May 1977 A
4041952 Morrison, Jr. et al. Aug 1977 A
4051855 Schneiderman Oct 1977 A
4074719 Semm Feb 1978 A
4092986 Schneiderman Jun 1978 A
4094320 Newton et al. Jun 1978 A
4097773 Lindmark Jun 1978 A
4102341 Ikuno et al. Jul 1978 A
4114623 Meinke et al. Sep 1978 A
4121590 Gonser Oct 1978 A
4123673 Gonser Oct 1978 A
4126137 Archibald Nov 1978 A
4171700 Farin Oct 1979 A
4188927 Harris Feb 1980 A
4191188 Belt et al. Mar 1980 A
4196734 Harris Apr 1980 A
4200104 Harris Apr 1980 A
4200105 Gonser Apr 1980 A
4209018 Meinke et al. Jun 1980 A
4231372 Newton Nov 1980 A
4232676 Herczog Nov 1980 A
4237887 Gosner Dec 1980 A
4281373 Mabille Jul 1981 A
4287557 Brehse Sep 1981 A
4296413 Milkovic Oct 1981 A
4303073 Archibald Dec 1981 A
4311154 Sterzer et al. Jan 1982 A
4314559 Allen Feb 1982 A
4321926 Roge Mar 1982 A
4334539 Childs et al. Jun 1982 A
4343308 Gross Aug 1982 A
4372315 Shapiro et al. Feb 1983 A
4376263 Pittroff et al. Mar 1983 A
4378801 Oosten Apr 1983 A
4384582 Watt May 1983 A
4397314 Vaguine Aug 1983 A
4411266 Cosman Oct 1983 A
4416276 Newton et al. Nov 1983 A
4416277 Newton et al. Nov 1983 A
4429694 McGreevy Feb 1984 A
4436091 Banko Mar 1984 A
4437464 Crow Mar 1984 A
4438766 Bowers Mar 1984 A
4463759 Garito et al. Aug 1984 A
4472661 Culver Sep 1984 A
4474179 Koch Oct 1984 A
4492231 Auth Jan 1985 A
4492832 Taylor Jan 1985 A
4494541 Archibald Jan 1985 A
4514619 Kugelman Apr 1985 A
4520818 Mickiewicz Jun 1985 A
4559496 Harnden, Jr. et al. Dec 1985 A
4559943 Bowers Dec 1985 A
4565200 Cosman Jan 1986 A
4566454 Mehl et al. Jan 1986 A
4569345 Manes Feb 1986 A
4582057 Auth et al. Apr 1986 A
4586120 Malik et al. Apr 1986 A
4590934 Malis et al. May 1986 A
4595248 Brown Jun 1986 A
4608977 Brown Sep 1986 A
4615330 Nagasaki et al. Oct 1986 A
4630218 Hurley Dec 1986 A
4632109 Patterson Dec 1986 A
4644955 Mioduski Feb 1987 A
4651264 Hu Mar 1987 A
4651280 Chang et al. Mar 1987 A
4657015 Irnich Apr 1987 A
4658815 Farin et al. Apr 1987 A
4658819 Harris et al. Apr 1987 A
4658820 Klicek Apr 1987 A
4662383 Sogawa et al. May 1987 A
4691703 Auth et al. Sep 1987 A
4727874 Bowers et al. Mar 1988 A
4735204 Sussman et al. Apr 1988 A
4739759 Rexroth et al. Apr 1988 A
4741334 Irnich May 1988 A
4754757 Feucht Jul 1988 A
4767999 VerPlanck Aug 1988 A
4768969 Bauer et al. Sep 1988 A
4788634 Schlecht et al. Nov 1988 A
4805621 Heinze et al. Feb 1989 A
4818954 Flachenecker et al. Apr 1989 A
4827927 Newton May 1989 A
4848335 Manes Jul 1989 A
4860745 Farin et al. Aug 1989 A
4862889 Feucht Sep 1989 A
4887199 Whittle Dec 1989 A
4890610 Kirwan et al. Jan 1990 A
4903696 Stasz et al. Feb 1990 A
4907589 Cosman Mar 1990 A
4922210 Flachenecker et al. May 1990 A
4931047 Broadwin et al. Jun 1990 A
4931717 Gray et al. Jun 1990 A
4938761 Ensslin Jul 1990 A
4942313 Kinzel Jul 1990 A
4959606 Forge Sep 1990 A
4961047 Carder Oct 1990 A
4961435 Kitagawa et al. Oct 1990 A
4966597 Cosman Oct 1990 A
4969885 Farin Nov 1990 A
4992719 Harvey Feb 1991 A
4993430 Shimoyama et al. Feb 1991 A
4995877 Ams et al. Feb 1991 A
5015227 Broadwin et al. May 1991 A
5024668 Peters et al. Jun 1991 A
5044977 Vindigni Sep 1991 A
5067953 Feucht Nov 1991 A
5075839 Fisher et al. Dec 1991 A
5087257 Farin Feb 1992 A
5099840 Goble et al. Mar 1992 A
5103804 Abele et al. Apr 1992 A
5108389 Cosmescu Apr 1992 A
5108391 Flachenecker Apr 1992 A
5119284 Fisher et al. Jun 1992 A
5122137 Lennox Jun 1992 A
5133711 Hagen Jul 1992 A
5151102 Kamiyama et al. Sep 1992 A
5152762 McElhenney Oct 1992 A
5157603 Scheller et al. Oct 1992 A
5160334 Billings et al. Nov 1992 A
5161893 Shigezawa et al. Nov 1992 A
5167658 Ensslin Dec 1992 A
5167659 Ohtomo et al. Dec 1992 A
5190517 Zieve et al. Mar 1993 A
5196008 Kuenecke Mar 1993 A
5196009 Kirwan, Jr. Mar 1993 A
5201900 Nardella Apr 1993 A
5207691 Nardella May 1993 A
5230623 Guthrie et al. Jul 1993 A
5233515 Cosman Aug 1993 A
5234427 Ohtomo et al. Aug 1993 A
5249121 Baum et al. Sep 1993 A
5249585 Turner et al. Oct 1993 A
5254117 Rigby et al. Oct 1993 A
RE34432 Bertrand Nov 1993 E
5267994 Gentelia et al. Dec 1993 A
5267997 Farin Dec 1993 A
5281213 Milder et al. Jan 1994 A
5282840 Hudrlik Feb 1994 A
5290283 Suda Mar 1994 A
5295857 Toly Mar 1994 A
5300068 Rosar et al. Apr 1994 A
5300070 Gentelia Apr 1994 A
5304917 Somerville Apr 1994 A
5318563 Malis et al. Jun 1994 A
5323778 Kandarpa et al. Jun 1994 A
5324283 Heckele Jun 1994 A
5330518 Neilson et al. Jul 1994 A
5334183 Wuchinich Aug 1994 A
5334193 Nardella Aug 1994 A
5341807 Nardella Aug 1994 A
5342356 Ellman Aug 1994 A
5342357 Nardella Aug 1994 A
5342409 Mullett Aug 1994 A
5346406 Hoffman et al. Sep 1994 A
5346491 Oertli Sep 1994 A
5348554 Imran et al. Sep 1994 A
5370645 Klicek et al. Dec 1994 A
5370672 Fowler et al. Dec 1994 A
5370675 Edwards et al. Dec 1994 A
5372596 Klicek et al. Dec 1994 A
5383874 Jackson Jan 1995 A
5383876 Nardella Jan 1995 A
5383917 Desai et al. Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5400267 Denen et al. Mar 1995 A
5403311 Abele et al. Apr 1995 A
5403312 Yates et al. Apr 1995 A
5409000 Imran Apr 1995 A
5409485 Suda Apr 1995 A
5413573 Koivukangas May 1995 A
5414238 Steigerwald et al. May 1995 A
5417719 Hull et al. May 1995 A
5422567 Matsunaga Jun 1995 A
5422926 Smith et al. Jun 1995 A
5423808 Edwards et al. Jun 1995 A
5423809 Klicek Jun 1995 A
5423810 Goble et al. Jun 1995 A
5423811 Imran et al. Jun 1995 A
5425704 Sakurai et al. Jun 1995 A
5429596 Arias et al. Jul 1995 A
5430434 Lederer et al. Jul 1995 A
5432459 Thompson Jul 1995 A
5433739 Sluijter et al. Jul 1995 A
5436566 Thompson Jul 1995 A
5438302 Goble Aug 1995 A
5443463 Stern et al. Aug 1995 A
5445635 Denen Aug 1995 A
5451224 Goble et al. Sep 1995 A
5452725 Martenson Sep 1995 A
5454809 Janssen Oct 1995 A
5458597 Edwards et al. Oct 1995 A
5462521 Brucker et al. Oct 1995 A
5472441 Edwards et al. Dec 1995 A
5472443 Cordis et al. Dec 1995 A
5474464 Drewnicki Dec 1995 A
5480399 Hebborn Jan 1996 A
5483952 Aranyi Jan 1996 A
5496312 Klicek Mar 1996 A
5496313 Gentelia et al. Mar 1996 A
5496314 Eggers Mar 1996 A
5500012 Brucker et al. Mar 1996 A
5500616 Ochi Mar 1996 A
5511993 Yamada et al. Apr 1996 A
5514129 Smith May 1996 A
5520684 Imran May 1996 A
5531774 Schulman et al. Jul 1996 A
5534018 Wahlstrand et al. Jul 1996 A
5536267 Edwards et al. Jul 1996 A
5540677 Sinofsky Jul 1996 A
5540681 Strul et al. Jul 1996 A
5540682 Gardner et al. Jul 1996 A
5540683 Ichikawa Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5541376 Ladtkow et al. Jul 1996 A
5545161 Imran Aug 1996 A
5556396 Cohen et al. Sep 1996 A
5558671 Yates Sep 1996 A
5562720 Stern et al. Oct 1996 A
5569242 Lax et al. Oct 1996 A
5571147 Sluijter et al. Nov 1996 A
5573533 Strul Nov 1996 A
5584830 Ladd et al. Dec 1996 A
5588432 Crowley Dec 1996 A
5596466 Ochi Jan 1997 A
5599344 Paterson Feb 1997 A
5599345 Edwards et al. Feb 1997 A
5599348 Gentelia et al. Feb 1997 A
5605150 Radons et al. Feb 1997 A
5609560 Ichikawa et al. Mar 1997 A
5613966 Makower et al. Mar 1997 A
5620481 Desai et al. Apr 1997 A
5626575 Crenner May 1997 A
5628745 Bek May 1997 A
5628771 Mizukawa et al. May 1997 A
5643330 Holsheimer et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5647871 Levine et al. Jul 1997 A
5651780 Jackson et al. Jul 1997 A
5658322 Fleming Aug 1997 A
5660567 Nierlich et al. Aug 1997 A
5664953 Reylek Sep 1997 A
5674217 Wahlstrom et al. Oct 1997 A
5678568 Uchikubo et al. Oct 1997 A
5681307 McMahan Oct 1997 A
5685840 Schechter et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5693042 Boiarski et al. Dec 1997 A
5693078 Desai et al. Dec 1997 A
5694304 Telefus et al. Dec 1997 A
5695494 Becker Dec 1997 A
5696441 Mak et al. Dec 1997 A
5697925 Taylor Dec 1997 A
5697927 Imran et al. Dec 1997 A
5702386 Stern et al. Dec 1997 A
5702429 King Dec 1997 A
5707369 Vaitekunas et al. Jan 1998 A
5712772 Telefus et al. Jan 1998 A
5713896 Nardella Feb 1998 A
5718246 Vona Feb 1998 A
5720742 Zacharias Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
5722975 Edwards et al. Mar 1998 A
5729448 Haynie et al. Mar 1998 A
5733281 Nardella Mar 1998 A
5735846 Panescu et al. Apr 1998 A
5738683 Osypka Apr 1998 A
5743900 Hara Apr 1998 A
5743903 Stern et al. Apr 1998 A
5749869 Lindenmeier et al. May 1998 A
5749871 Hood et al. May 1998 A
5755715 Stern May 1998 A
5766153 Eggers et al. Jun 1998 A
5766165 Gentelia et al. Jun 1998 A
5769847 Panescu Jun 1998 A
5772659 Becker et al. Jun 1998 A
5788688 Bauer et al. Aug 1998 A
5792138 Shipp Aug 1998 A
5797902 Netherly Aug 1998 A
5807253 Dumoulin et al. Sep 1998 A
5810804 Gough et al. Sep 1998 A
5814092 King Sep 1998 A
5817091 Nardella et al. Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5820568 Willis Oct 1998 A
5827271 Bussey et al. Oct 1998 A
5830212 Cartmell Nov 1998 A
5836909 Cosmescu Nov 1998 A
5836943 Miller, III Nov 1998 A
5836990 Li Nov 1998 A
5843019 Eggers et al. Dec 1998 A
5843075 Taylor Dec 1998 A
5846236 Lindenmeier et al. Dec 1998 A
5849010 Wurzer et al. Dec 1998 A
5853409 Swanson et al. Dec 1998 A
5860832 Wayt et al. Jan 1999 A
5865788 Edwards et al. Feb 1999 A
5868737 Taylor et al. Feb 1999 A
5868739 Lindenmeier et al. Feb 1999 A
5868740 LeVeen et al. Feb 1999 A
5871481 Kannenberg et al. Feb 1999 A
5891142 Eggers et al. Apr 1999 A
5897552 Edwards et al. Apr 1999 A
5906614 Stern et al. May 1999 A
5908444 Azure Jun 1999 A
5913882 King Jun 1999 A
5921982 Lesh et al. Jul 1999 A
5925070 King et al. Jul 1999 A
5931836 Hatta et al. Aug 1999 A
5938690 Law et al. Aug 1999 A
5944553 Yasui et al. Aug 1999 A
5948007 Starkebaum et al. Sep 1999 A
5951545 Schilling Sep 1999 A
5951546 Lorentzen Sep 1999 A
5954686 Garito et al. Sep 1999 A
5954717 Behl et al. Sep 1999 A
5954719 Chen et al. Sep 1999 A
5957961 Maguire et al. Sep 1999 A
5959253 Shinchi Sep 1999 A
5961344 Rosales et al. Oct 1999 A
5964746 McCary Oct 1999 A
5971980 Sherman Oct 1999 A
5971981 Hill et al. Oct 1999 A
5976128 Schilling et al. Nov 1999 A
5983141 Sluijter et al. Nov 1999 A
6007532 Netherly Dec 1999 A
6010499 Cobb Jan 2000 A
6013074 Taylor Jan 2000 A
6014581 Whayne et al. Jan 2000 A
6017338 Brucker et al. Jan 2000 A
6022346 Panescu et al. Feb 2000 A
6022347 Lindenmeier et al. Feb 2000 A
6033399 Gines Mar 2000 A
6039731 Taylor et al. Mar 2000 A
6039732 Ichikawa et al. Mar 2000 A
6041260 Stern et al. Mar 2000 A
6044283 Fein et al. Mar 2000 A
6053910 Fleenor Apr 2000 A
6053912 Panescu et al. Apr 2000 A
6055458 Cochran et al. Apr 2000 A
6056745 Panescu et al. May 2000 A
6056746 Goble et al. May 2000 A
6059781 Yamanashi et al. May 2000 A
6063075 Mihori May 2000 A
6063078 Wittkampf May 2000 A
6066137 Greep May 2000 A
6068627 Orszulak et al. May 2000 A
6074089 Hollander et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
6074388 Tockweiler et al. Jun 2000 A
6080149 Huang et al. Jun 2000 A
6088614 Swanson Jul 2000 A
6093186 Goble Jul 2000 A
6102497 Ehr et al. Aug 2000 A
6102907 Smethers et al. Aug 2000 A
6113591 Whayne et al. Sep 2000 A
6113592 Taylor Sep 2000 A
6113593 Tu et al. Sep 2000 A
6113596 Hooven Sep 2000 A
6123701 Nezhat Sep 2000 A
6123702 Swanson et al. Sep 2000 A
6132429 Baker Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6155975 Urich et al. Dec 2000 A
6162184 Swanson et al. Dec 2000 A
6162217 Kannenberg et al. Dec 2000 A
6165169 Panescu et al. Dec 2000 A
6171304 Netherly et al. Jan 2001 B1
6183468 Swanson et al. Feb 2001 B1
6186147 Cobb Feb 2001 B1
6188211 Rincon-Mora et al. Feb 2001 B1
6193713 Geistert et al. Feb 2001 B1
6197023 Muntermann Mar 2001 B1
6203541 Keppel Mar 2001 B1
6210403 Klicek Apr 2001 B1
6216704 Ingle et al. Apr 2001 B1
6222356 Taghizadeh-Kaschani Apr 2001 B1
6228078 Eggers et al. May 2001 B1
6228080 Gines May 2001 B1
6228081 Goble May 2001 B1
6231569 Bek et al May 2001 B1
6232556 Daugherty et al. May 2001 B1
6235020 Cheng et al. May 2001 B1
6235022 Hallock et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238387 Miller, III May 2001 B1
6238388 Ellman May 2001 B1
6241723 Heim et al. Jun 2001 B1
6241725 Cosman Jun 2001 B1
6243654 Johnson et al. Jun 2001 B1
6245061 Panescu et al. Jun 2001 B1
6245063 Uphoff Jun 2001 B1
6245065 Panescu Jun 2001 B1
6246912 Sluijter et al. Jun 2001 B1
6251106 Becker et al. Jun 2001 B1
6254422 Feye-Hohmann Jul 2001 B1
6258085 Eggleston Jul 2001 B1
6261285 Novak Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6267760 Swanson Jul 2001 B1
6273886 Edwards Aug 2001 B1
6275786 Daners Aug 2001 B1
6293941 Strul Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6293943 Panescu et al. Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6306131 Hareyama et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6309386 Bek Oct 2001 B1
6322558 Taylor et al. Nov 2001 B1
6325799 Goble Dec 2001 B1
6337998 Behl et al. Jan 2002 B1
6338657 Harper et al. Jan 2002 B1
6350262 Ashley Feb 2002 B1
6358245 Edwards Mar 2002 B1
6364877 Goble et al. Apr 2002 B1
6371963 Nishtala et al. Apr 2002 B1
6383183 Sekino et al. May 2002 B1
6391024 Sun et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
6402741 Keppel et al. Jun 2002 B1
6402742 Blewett et al. Jun 2002 B1
6402743 Orszulak et al. Jun 2002 B1
6402748 Schoenman et al. Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
6413256 Truckai et al. Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6422896 Aoki et al. Jul 2002 B2
6423057 He et al. Jul 2002 B1
6426886 Goder Jul 2002 B1
6428537 Swanson et al. Aug 2002 B1
6436096 Hareyama Aug 2002 B1
6440157 Shigezawa et al. Aug 2002 B1
6451015 Rittman, III et al. Sep 2002 B1
6454594 Sawayanagi Sep 2002 B2
6458121 Rosenstock Oct 2002 B1
6458122 Pozzato Oct 2002 B1
6464689 Qin Oct 2002 B1
6464696 Oyama Oct 2002 B1
6468270 Hovda et al. Oct 2002 B1
6468273 Leveen et al. Oct 2002 B1
6482201 Olsen et al. Nov 2002 B1
6488678 Sherman Dec 2002 B2
6494880 Swanson et al. Dec 2002 B1
6497659 Rafert Dec 2002 B1
6498466 Edwards Dec 2002 B1
6506189 Rittman, III et al. Jan 2003 B1
6508815 Strul Jan 2003 B1
6511476 Hareyama Jan 2003 B2
6511478 Burnside Jan 2003 B1
6517538 Jacob et al. Feb 2003 B1
6522931 Manker et al. Feb 2003 B2
6524308 Muller et al. Feb 2003 B1
6537272 Christopherson et al. Mar 2003 B2
6544260 Markel et al. Apr 2003 B1
6546270 Goldin et al. Apr 2003 B1
6546370 Heo Apr 2003 B2
6547786 Goble Apr 2003 B1
6557559 Eggers et al. May 2003 B1
6558376 Bishop May 2003 B2
6558377 Lee et al. May 2003 B2
6560470 Pologe May 2003 B1
6562037 Paton May 2003 B2
6565559 Eggleston May 2003 B2
6565562 Shah et al. May 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6578579 Burnside et al. Jun 2003 B2
6579288 Swanson et al. Jun 2003 B1
6582427 Goble et al. Jun 2003 B1
6602243 Noda Aug 2003 B2
6602252 Mollenauer Aug 2003 B2
6611793 Burnside et al. Aug 2003 B1
6620157 Dabney et al. Sep 2003 B1
6620189 Bloom et al. Sep 2003 B1
6623423 Sakurai Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6629973 Wardell et al. Oct 2003 B1
6632193 Davison et al. Oct 2003 B1
6635056 Kadhiresan et al. Oct 2003 B2
6635057 Harano Oct 2003 B2
6645198 Bommannan et al. Nov 2003 B1
6648883 Francischelli Nov 2003 B2
6651669 Burnside Nov 2003 B1
6652513 Panescu et al. Nov 2003 B2
6652514 Ellman Nov 2003 B2
6653569 Sung Nov 2003 B1
6656177 Truckai et al. Dec 2003 B2
6663623 Oyama et al. Dec 2003 B1
6663624 Edwards Dec 2003 B2
6663627 Francischelli et al. Dec 2003 B2
6666860 Takahashi Dec 2003 B1
6672151 Schultz et al. Jan 2004 B1
6679875 Honda Jan 2004 B2
6682527 Strul Jan 2004 B2
6685700 Behl Feb 2004 B2
6685701 Orszulak et al. Feb 2004 B2
6685703 Pearson et al. Feb 2004 B2
6689131 McClurken Feb 2004 B2
6692489 Heim Feb 2004 B1
6693782 Lash Feb 2004 B1
6695837 Howell Feb 2004 B2
6696844 Wong et al. Feb 2004 B2
6712813 Ellman Mar 2004 B2
6730078 Simpson et al. May 2004 B2
6730079 Lovewell May 2004 B2
6730080 Harano May 2004 B2
6733495 Bek May 2004 B1
6733498 Paton May 2004 B2
6740079 Eggers May 2004 B1
6740085 Hareyama May 2004 B2
6743225 Sanchez et al. Jun 2004 B2
6746284 Spink, Jr. Jun 2004 B1
6749624 Knowlton Jun 2004 B2
6755825 Shoenman et al. Jun 2004 B2
6758846 Goble et al. Jul 2004 B2
6761716 Kadhiresan et al. Jul 2004 B2
6783523 Qin Aug 2004 B2
6784405 Flugstad et al. Aug 2004 B2
6786905 Swanson et al. Sep 2004 B2
6790206 Panescu Sep 2004 B2
6792390 Burnside et al. Sep 2004 B1
6796980 Hall Sep 2004 B2
6796981 Wham Sep 2004 B2
6809508 Donofrio Oct 2004 B2
6818000 Muller et al. Nov 2004 B2
6824539 Novak Nov 2004 B2
6830569 Thompson Dec 2004 B2
6837888 Ciarrocca et al. Jan 2005 B2
6843682 Matsuda et al. Jan 2005 B2
6843789 Goble Jan 2005 B2
6849073 Hoey Feb 2005 B2
6855141 Lovewell Feb 2005 B2
6855142 Harano Feb 2005 B2
6860881 Sturm Mar 2005 B2
6864686 Novak Mar 2005 B2
6875210 Refior Apr 2005 B2
6890331 Kristensen May 2005 B2
6893435 Goble May 2005 B2
6899538 Matoba May 2005 B2
6923804 Eggers et al. Aug 2005 B2
6929641 Goble et al. Aug 2005 B2
6936047 Nasab et al. Aug 2005 B2
6939344 Kreindel Sep 2005 B2
6939346 Kannenberg et al. Sep 2005 B2
6939347 Thompson Sep 2005 B2
6942660 Pantera et al. Sep 2005 B2
6948503 Refior et al. Sep 2005 B2
6958064 Rioux et al. Oct 2005 B2
6962587 Johnson et al. Nov 2005 B2
6966907 Goble Nov 2005 B2
6974453 Woloszko et al. Dec 2005 B2
6974463 Magers et al. Dec 2005 B2
6977495 Donofrio Dec 2005 B2
6984231 Goble et al. Jan 2006 B2
6989010 Francischelli et al. Jan 2006 B2
6994704 Qin et al. Feb 2006 B2
6994707 Ellman et al. Feb 2006 B2
7001379 Behl et al. Feb 2006 B2
7001381 Harano et al. Feb 2006 B2
7004174 Eggers et al. Feb 2006 B2
7008369 Cuppen Mar 2006 B2
7008417 Eick Mar 2006 B2
7008421 Daniel et al. Mar 2006 B2
7025764 Paton et al. Apr 2006 B2
7033351 Howell Apr 2006 B2
7041096 Malis et al. May 2006 B2
7044948 Keppel May 2006 B2
7044949 Orszulak et al. May 2006 B2
7060063 Marion et al. Jun 2006 B2
7062331 Zarinetchi et al. Jun 2006 B2
7063692 Sakurai et al. Jun 2006 B2
7066933 Hagg Jun 2006 B2
7074217 Strul et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7094231 Ellman et al. Aug 2006 B1
RE39358 Goble Oct 2006 E
7115121 Novak Oct 2006 B2
7115124 Xiao Oct 2006 B1
7118564 Ritchie et al. Oct 2006 B2
7122031 Edwards et al. Oct 2006 B2
7131445 Amoah Nov 2006 B2
7131860 Sartor et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7146210 Palti Dec 2006 B2
7147638 Chapman et al. Dec 2006 B2
7151964 Desai et al. Dec 2006 B2
7153300 Goble Dec 2006 B2
7156844 Reschke et al. Jan 2007 B2
7156846 Dycus et al. Jan 2007 B2
7160293 Sturm et al. Jan 2007 B2
7163536 Godara Jan 2007 B2
7169144 Hoey et al. Jan 2007 B2
7172591 Harano et al. Feb 2007 B2
7175618 Dabney et al. Feb 2007 B2
7175621 Heim et al. Feb 2007 B2
7192427 Chapelon et al. Mar 2007 B2
7195627 Amoah et al. Mar 2007 B2
7203556 Daners Apr 2007 B2
7211081 Goble May 2007 B2
7214224 Goble May 2007 B2
7217269 El-Galley et al. May 2007 B2
7220260 Fleming et al. May 2007 B2
7223264 Daniel et al. May 2007 B2
7226447 Uchida et al. Jun 2007 B2
7229469 Witzel et al. Jun 2007 B1
7232437 Berman et al. Jun 2007 B2
7238181 Daners et al. Jul 2007 B2
7238183 Kreindel Jul 2007 B2
7244255 Daners et al. Jul 2007 B2
7247155 Hoey et al. Jul 2007 B2
7250048 Francischelli et al. Jul 2007 B2
7250746 Oswald et al. Jul 2007 B2
7255694 Keppel Aug 2007 B2
7258688 Shah et al. Aug 2007 B1
7282048 Goble et al. Oct 2007 B2
7282049 Orszulak et al. Oct 2007 B2
7285117 Krueger et al. Oct 2007 B2
7294127 Leung et al. Nov 2007 B2
7300435 Wham et al. Nov 2007 B2
7300437 Pozzato Nov 2007 B2
7303557 Wham et al. Dec 2007 B2
7305311 Van Zyl Dec 2007 B2
7317954 McGreevy Jan 2008 B2
7317955 McGreevy Jan 2008 B2
7324357 Miura et al. Jan 2008 B2
7333859 Rinaldi et al. Feb 2008 B2
7341586 Daniel et al. Mar 2008 B2
7344532 Goble et al. Mar 2008 B2
7353068 Tanaka et al. Apr 2008 B2
7354436 Rioux et al. Apr 2008 B2
7357800 Swanson Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
7364578 Francischelli et al. Apr 2008 B2
7364972 Ono et al. Apr 2008 B2
7367972 Francischelli et al. May 2008 B2
RE40388 Gines Jun 2008 E
7396336 Orszulak et al. Jul 2008 B2
7402754 Kirwan, Jr. et al. Jul 2008 B2
D574323 Waaler Aug 2008 S
7407502 Strul et al. Aug 2008 B2
7416437 Sartor et al. Aug 2008 B2
7416549 Young et al. Aug 2008 B2
7422582 Malackowski et al. Sep 2008 B2
7422586 Morris et al. Sep 2008 B2
7425835 Eisele Sep 2008 B2
7465302 Odell et al. Dec 2008 B2
7470272 Mulier et al. Dec 2008 B2
7479140 Ellman et al. Jan 2009 B2
7491199 Goble Feb 2009 B2
7491201 Shields et al. Feb 2009 B2
7513896 Orszulak Apr 2009 B2
7525398 Nishimura et al. Apr 2009 B2
20010014804 Goble et al. Aug 2001 A1
20010029315 Sakurai et al. Oct 2001 A1
20010031962 Eggleston Oct 2001 A1
20020035363 Edwards et al. Mar 2002 A1
20020035364 Schoenman et al. Mar 2002 A1
20020052599 Goble May 2002 A1
20020068932 Edwards Jun 2002 A1
20020107517 Witt et al. Aug 2002 A1
20020111624 Witt et al. Aug 2002 A1
20020151889 Swanson et al. Oct 2002 A1
20020193787 Qin Dec 2002 A1
20030004510 Wham et al. Jan 2003 A1
20030060818 Kannenberg Mar 2003 A1
20030078572 Pearson et al. Apr 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030153908 Goble Aug 2003 A1
20030163123 Goble Aug 2003 A1
20030163124 Goble Aug 2003 A1
20030171745 Francischelli Sep 2003 A1
20030181898 Bowers Sep 2003 A1
20030199863 Swanson Oct 2003 A1
20030225401 Eggers et al. Dec 2003 A1
20040002745 Fleming Jan 2004 A1
20040015159 Slater et al. Jan 2004 A1
20040015163 Buysse et al. Jan 2004 A1
20040015216 DeSisto Jan 2004 A1
20040019347 Sakurai Jan 2004 A1
20040024395 Ellman Feb 2004 A1
20040030328 Eggers Feb 2004 A1
20040030330 Brassell et al. Feb 2004 A1
20040044339 Beller Mar 2004 A1
20040049179 Francischelli Mar 2004 A1
20040054365 Goble Mar 2004 A1
20040059323 Sturm et al. Mar 2004 A1
20040068304 Paton Apr 2004 A1
20040082946 Malis Apr 2004 A1
20040095100 Thompson May 2004 A1
20040097912 Gonnering May 2004 A1
20040097914 Pantera May 2004 A1
20040097915 Refior May 2004 A1
20040116919 Heim Jun 2004 A1
20040133189 Sakurai Jul 2004 A1
20040138653 Dabney et al. Jul 2004 A1
20040138654 Goble Jul 2004 A1
20040143263 Schechter et al. Jul 2004 A1
20040147918 Keppel Jul 2004 A1
20040167508 Wham et al. Aug 2004 A1
20040172016 Bek Sep 2004 A1
20040193148 Wham et al. Sep 2004 A1
20040230189 Keppel Nov 2004 A1
20040243120 Orszulak et al. Dec 2004 A1
20040260279 Goble Dec 2004 A1
20050004564 Wham Jan 2005 A1
20050004569 Witt et al. Jan 2005 A1
20050004634 Ricart et al. Jan 2005 A1
20050021020 Blaha et al. Jan 2005 A1
20050021022 Sturm et al. Jan 2005 A1
20050070896 Daniel et al. Mar 2005 A1
20050101949 Harano et al. May 2005 A1
20050101951 Wham May 2005 A1
20050109111 Manlove et al. May 2005 A1
20050113818 Sartor May 2005 A1
20050113819 Wham May 2005 A1
20050149151 Orszulak Jul 2005 A1
20050182398 Paterson Aug 2005 A1
20050197659 Bahney Sep 2005 A1
20050203504 Wham et al. Sep 2005 A1
20060025760 Podhajsky Feb 2006 A1
20060079871 Plaven et al. Apr 2006 A1
20060111711 Goble May 2006 A1
20060161148 Behnke Jul 2006 A1
20060178664 Keppel Aug 2006 A1
20060224152 Behnke et al. Oct 2006 A1
20060281360 Sartor et al. Dec 2006 A1
20060291178 Shih Dec 2006 A1
20070038209 Buysse et al. Feb 2007 A1
20070093800 Wham et al. Apr 2007 A1
20070093801 Behnke Apr 2007 A1
20070135812 Sartor Jun 2007 A1
20070173802 Keppel Jul 2007 A1
20070173803 Wham et al. Jul 2007 A1
20070173804 Wham et al. Jul 2007 A1
20070173805 Weinberg et al. Jul 2007 A1
20070173806 Orszulak et al. Jul 2007 A1
20070173810 Orszulak Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070208339 Arts et al. Sep 2007 A1
20070225698 Orszulak et al. Sep 2007 A1
20070250052 Wham Oct 2007 A1
20070265612 Behnke et al. Nov 2007 A1
20070282320 Buysse et al. Dec 2007 A1
20080015563 Hoey et al. Jan 2008 A1
20080015564 Wham et al. Jan 2008 A1
20080039831 Odom et al. Feb 2008 A1
20080039836 Odom et al. Feb 2008 A1
20080082094 McPherson et al. Apr 2008 A1
20080125767 Blaha May 2008 A1
20080177199 Podhajsky Jul 2008 A1
20080248685 Sartor et al. Oct 2008 A1
20080281315 Gines Nov 2008 A1
20080281316 Carlton et al. Nov 2008 A1
20080287791 Orszulak et al. Nov 2008 A1
20080287838 Orszulak et al. Nov 2008 A1
20090018536 Behnke Jan 2009 A1
20090024120 Sartor Jan 2009 A1
20090036883 Behnke Feb 2009 A1
20090069801 Jensen et al. Mar 2009 A1
20090082765 Collins et al. Mar 2009 A1
20090157071 Wham et al. Jun 2009 A1
20090157072 Wham et al. Jun 2009 A1
20090157073 Orszulak Jun 2009 A1
20090157075 Wham et al. Jun 2009 A1
Foreign Referenced Citations (117)
Number Date Country
179607 Mar 1905 DE
1099658 Feb 1961 DE
1139927 Nov 1962 DE
1149832 Jun 1963 DE
1439302 Jan 1969 DE
2439587 Feb 1975 DE
2455174 May 1975 DE
2407559 Aug 1975 DE
2602517 Jul 1976 DE
2504280 Aug 1976 DE
2540968 Mar 1977 DE
2820908 Nov 1978 DE
2803275 Aug 1979 DE
2823291 Nov 1979 DE
2946728 May 1981 DE
3143421 May 1982 DE
3045996 Jul 1982 DE
3120102 Dec 1982 DE
3510586 Oct 1986 DE
3604823 Aug 1987 DE
390937 Apr 1989 DE
3904558 Aug 1990 DE
3942998 Jul 1991 DE
4339049 May 1995 DE
19717411 Nov 1998 DE
19848540 May 2000 DE
246350 Nov 1987 EP
310431 Apr 1989 EP
325456 Jul 1989 EP
336742 Oct 1989 EP
390937 Oct 1990 EP
556705 Aug 1993 EP
569130 Nov 1993 EP
608609 Aug 1994 EP
0640317 Mar 1995 EP
0694291 Jan 1996 EP
836868 Apr 1998 EP
878169 Nov 1998 EP
1051948 Nov 2000 EP
1053720 Nov 2000 EP
1151725 Nov 2001 EP
1293171 Mar 2003 EP
1472984 Nov 2004 EP
1495712 Jan 2005 EP
1500378 Jan 2005 EP
1535581 Jun 2005 EP
1609430 Dec 2005 EP
1707144 Mar 2006 EP
1645235 Apr 2006 EP
880220 Jun 2006 EP
1707143 Oct 2006 EP
1744354 Jan 2007 EP
1810628 Jul 2007 EP
1810630 Jul 2007 EP
1810633 Jul 2007 EP
1854423 Nov 2007 EP
1275415 Oct 1961 FR
1347865 Nov 1963 FR
2313708 Dec 1976 FR
2364461 Jul 1978 FR
2502935 Oct 1982 FR
2517953 Jun 1983 FR
2573301 May 1986 FR
607850 Sep 1948 GB
702510 Jan 1954 GB
855459 Nov 1960 GB
902775 Aug 1962 GB
2164473 Mar 1986 GB
2214430 Sep 1989 GB
2358934 Aug 2001 GB
166452 Jan 1965 SU
727201 Apr 1980 SU
WO9206642 Apr 1992 WO
WO9324066 Dec 1993 WO
WO9410922 May 1994 WO
WO9424949 Nov 1994 WO
WO9428809 Dec 1994 WO
WO9509577 Apr 1995 WO
WO9519148 Jul 1995 WO
WO9525471 Sep 1995 WO
WO9602180 Feb 1996 WO
WO9604860 Feb 1996 WO
WO9608794 Mar 1996 WO
WO9618349 Jun 1996 WO
WO9629946 Oct 1996 WO
WO9639086 Dec 1996 WO
WO9639914 Dec 1996 WO
WO9706739 Feb 1997 WO
WO9706740 Feb 1997 WO
WO9706855 Feb 1997 WO
WO9711648 Apr 1997 WO
WO9717029 May 1997 WO
WO9807378 Feb 1998 WO
WO9818395 May 1998 WO
WO9827880 Jul 1998 WO
WO9912607 Mar 1999 WO
WO0200129 Jan 2002 WO
WO0211634 Feb 2002 WO
WO0245589 Jun 2002 WO
WO0247565 Jun 2002 WO
WO02053048 Jul 2002 WO
WO02088128 Jul 2002 WO
WO03090630 Nov 2003 WO
WO03090635 Nov 2003 WO
WO03092520 Nov 2003 WO
WO2004028385 Apr 2004 WO
WO2004098385 Apr 2004 WO
WO2004043240 May 2004 WO
WO2004052182 Jun 2004 WO
WO2004103156 Dec 2004 WO
WO2005046496 May 2005 WO
WO2005048809 Jun 2005 WO
WO2005050151 Jun 2005 WO
WO2005060365 Jul 2005 WO
WO2005060849 Jul 2005 WO
WO2006050888 May 2006 WO
WO2006105121 Oct 2006 WO
Non-Patent Literature Citations (63)
Entry
Alexander et al., “Magnetic Resonance Image-Directed Stereotactic Neurosurgery: Use of Image Fusion with Computerized Tomography to Enhance Spatial Accuracy” Journal Neurosurgery, 83; (1995) pp. 271-276.
Anderson et al., “A Numerical Study of Rapid Heating for High Temperature Radio Frequency Hyperthermia” International Journal of Bio-Medical Computing, 35 (1994) pp. 297-307.
Astrahan, “A Localized Current Field Hyperthermia System for Use with 192-Iridium Interstitial Implants” Medical Physics, 9 (3), May/Jun. 1982.
Bergdahl et al., “Studies on Coagulation and the Development of an Automatic Computerized Bipolar Coagulator” Journal of Neurosurgery 75:1, (Jul. 1991) pp. 148-151.
Chicharo et al. “A Sliding Goertzel Algorith” Aug. 1996, pp. 283-297 Signal Processing, Elsevier Science Publishers B.V. Amsterdam, NL vol. 52 No. 3.
Cosman et al., “Methods of Making Nervous System Lesions” In William RH, Rengachary SS (eds): Neurosurgery, New York: McGraw-Hill, vol. 111, (1984), pp. 2490-2499.
Cosman et al., “Radiofrequency Lesion Generation and Its Effect on Tissue Impedance” Applied Neurophysiology 51: (1988) pp. 230-242.
Cosman et al., “Theoretical Aspects of Radiofrequency Lesions in the Dorsal Root Entry Zone” Neurosurgery 15:(1984) pp. 945-950.
Geddes et al., “The Measurement of Physiologic Events by Electrical Impedence” Am. J. MI, Jan. Mar. 1964, pp. 16-27.
Goldberg et al., “Tissue Ablation with Radiofrequency: Effect of Probe Size, Gauge, Duration, and Temperature on Lesion Volume”Acad Radio (1995) vol. 2, No. 5, pp. 399-404.
Medtrex Brochure 'The O.R. Pro 300 1 p. Sep. 1998.
Ogden Goertzel Alternative to the Fourier Transform: Jun. 1993 pp. 485-487 Electronics World; Reed Business Publishing, Sutton, Surrey, BG vol. 99, No. 9. 1687.
Sugita et al., “Bipolar Coagulator with Automatic Thermocontrol” J. Neurosurg., vol. 41, Dec. 1944, pp. 777-779.
Valleylab Brochure “Valleylab Electroshield Monitoring System” 2 pp. Nov. 1995.
Vallfors et al., “Automatically Controlled Bipolar Electrosoagulation—‘COA-COMP’” Neurosurgical Review 7:2-3 (1984) pp. 187-190.
Wald et al., “Accidental Burns”, JAMA, Aug. 16, 1971, vol. 217, No. 7, pp. 916-921.
Richard Wolf Medical Instruments Corp. Brochure, “Kleppinger Bipolar Forceps & Bipolar Generator” 3 pp. Jan. 1989.
Ni W. et al. “A Signal Processing Method for the Coriolis Mass Flowmeter Based on a Normalized . . . ” Journal of Applied Sciences—Yingyong Kexue Xuebao, Shangha CN, vol. 23 No. 2;(Mar. 2005); pp. 160-164.
International Search Report PCT/US03/37110 dated Jul. 25, 2005.
International Search Report PCT/US03/37310 dated Aug. 13, 2004.
International Search Report EP 04009964 dated Jul. 13, 2004.
International Search Report EP 98300964.8 dated Dec. 4, 2000.
International Search Report EP 04015981.6 dated Sep. 29, 2004.
International Search Report EP 05014156.3 dated Dec. 28, 2005.
International Search Report EP 05021944.3 dated Jan. 18, 2006.
International Search Report EP 05022350.2 dated Jan. 18, 2006.
International Search Report EP 05002769.7 dated Jun. 9, 2006.
International Search Report EP 06000708.5 dated Apr. 21, 2006.
International Search Report—extended EP 06000708.5 dated Aug. 22, 2006.
International Search Report EP 06006717.0 dated Aug. 7, 2006.
International Search Report EP 07008207.8; dated Sep. 5, 2007.
International Search Report EP 07010673.7; dated Sep. 24, 2007.
US 6,878,148, 4/2005, Goble et al. (withdrawn).
Hadley I C D et al., “Inexpensive Digital Thermometer for Measurements on Semiconductors” International Journal of Electronics; Taylor and Francis. Ltd.; London, GB; vol. 70, No. 6 Jun. 1, 1991; pp. 1155-1162.
International Search Report EP04707738 dated Jul. 4, 2007.
International Search Report EP08004667.5 dated Jun. 3, 2008.
International Search Report EP08006733.3 dated Jul. 28, 2008.
International Search Report EP08012503 dated Sep. 19, 2008.
International Search Report EP08013605 dated Nov. 17, 2008.
International Search Report EP08015601.1 dated Dec. 5, 2008.
International Search Report EP08016540.0 dated Feb. 25, 2009.
International Search Report EP08155780 dated Jan. 19, 2009.
International Search Report EP08166208.2 dated Dec. 1, 2008.
International Search Report PCT/US03/33711 dated Jul. 16, 2004.
International Search Report PCT/US03/33832 dated Jun. 17, 2004.
International Search Report PCT/US04/02961 dated Aug. 2, 2005.
International Search Report EP06022028.2 dated Feb. 5, 2007.
International Search Report EP06025700.3 dated Apr. 12, 2007.
International Search Report EP07001481.6 dated Apr. 23, 2007.
International Search Report EP07001485.7 dated May 15, 2007.
International Search Report EP07001527.6 dated May 9, 2007.
International Search Report EP07004355.9 dated May 21, 2007.
Muller et al., “Extended Left Hemicolectomy Using the LigaSure Vessel Sealing System” Innovations That Work; Sep. 1999.
International Search Report EP 06010499.9 dated Jan. 29, 2008.
International Search Report EP 07001489.9 dated Dec. 20, 2007.
International Search Report EP 07001491 dated Jun. 6, 2007.
International Search Report EP 07009322.4 dated Jan. 14, 2008.
International Search Report EP 07015601.3 dated Jan. 4, 2008.
International Search Report EP 07015602.1 dated Dec. 20, 2007.
International Search Report EP 07019174.7 dated Jan. 29, 2008.
International Search Report EP07001494.9 dated Aug. 12, 2010.
Extended European Search Report from corresponding European Patent Application No. 07001494.9 mailed Mar. 7, 2011.
Examiner's First Report issued in the corresponding Australian Application No. 2007200292 dated Dec. 9, 2011.
Related Publications (1)
Number Date Country
20070173805 A1 Jul 2007 US
Provisional Applications (1)
Number Date Country
60761498 Jan 2006 US